SEC Filing Madrigal Pharmaceuticals.

DEF 14A

Madrigal Pharmaceuticals Inc - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of

Companies

Madrigal Pharmaceuticals: A Deeper Look At A Looming NASH Play (NASDAQ:MDGL)

Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering

g560783.jpg

SEC Filing NeuroBo Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Inc Trademarks & Logos

10-K

American Century Companies Inc. Increases Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Madrigal Pharmaceuticals: Wait For NASH Data Must End Soon

SEC Filing NeuroBo Pharmaceuticals, Inc.

American Century Companies Inc. Increases Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Madrigal Pharmaceuticals Inc - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of

Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening General Session of the EASL Congress™